New analysis shows rising ER visits for repeat opioid-related emergencies

New analysis shows rising ER visits for repeat opioid-related emergencies

Patients caught in crossfire between giant hospital chain, large insurer Patients with greater numbers of previous opioid-related ED visits, previous unique number hospital systems for which they've had an ED encounter, heroin use being documented at the encounter, those insured by Medicaid or uninsured relative to privately insured were more likely to have a future emergency department encounter for opioid-related emergencies, according to the analysis. The analysis of 9,295 patients in four Indiana hospital systems was conducted with data from a statewide regional Health Information Exchange system that examined prescription history, visit detail, and community characteristics. "Consolidating patient information from multiple emergency departments can improve risk assessment and help identify more opportunities to provide patients with treatment, particularly those who have multiple ED visits for opioid-related health emergencies. More effective use of health information can enable more efficient care for these individuals," said Balio. Source: American College of Emergency Physicians Journal reference: Balio, C.P., et al. (2020) Opioid-Related Emergency Department Encounters: Patient, Encounter, and Community Characteristics Associated With Repeated Encounters. Annals of Emergency Medicine . doi.org/10.1016/j.annemergmed.2019.12.005 .



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More